265
Views
3
CrossRef citations to date
0
Altmetric
Letters to the Editor

Bilateral Panuveitis with Occlusive Vasculitis following Coronavirus Disease 2019 Vaccination

, MD, MSc, , MD, MSc & , MD, MSc
Pages 660-664 | Received 22 Dec 2021, Accepted 05 Feb 2022, Published online: 28 Feb 2022
 

ABSTRACT

Purpose

To report a case of bilateral panuveitis and occlusive vasculitis following COVID-19 vaccination.

Study design

Case report.

Results

A 41-year-old otherwise healthy male presented with progressive vision loss and floaters starting 48 hours after a first dose of COVID-19 vaccine. Examination initially showed bilateral anterior uveitis, but this evolved into bilateral panuveitis with occlusive vasculitis despite topical corticosteroids over two weeks. The patient underwent extensive testing for other etiologies which were excluded. He was successfully treated with a gradual taper of topical and systemic corticosteroids leading to improvement of signs and symptoms. Follow-up is maintained for observation of avascular zones with possible neovascularization which could require laser as needed.

Conclusions

The temporal association between vaccine and presentation makes this a plausible etiology. This remains a rare adverse event, but clinicians should be aware of this possibility to include it in their differential diagnosis when confronted with idiosyncratic ocular presentations.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Ethics approval

The Institutional Review Board of the Centre hospitalier universitaire de Québec – Université Laval waived the need to review this study (2022-6213). The patient provided written consent for the publication of this case.

Additional information

Funding

The author(s) reported there is no funding associated with the work featured in this article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.